Skip to main content
. 2023 Nov 3;10:1173106. doi: 10.3389/fnut.2023.1173106

Table 1.

Characteristics and predictors for analysis in both subsamples.

Less than three months (n = 93) More than three months (n = 20) p value Effect size (r)
Median (IQR) Range (Min-Max) Median (IQR) Range (Min-Max)
Age [years] 60 (52–69.5) 20–85 61.5 (54–70) 29–78 0.596 0.05
BMI [kg/m2] 20.3 (17.4–22.7) 12.5–29.3 18.7 (17.2–21.1) 14.4–28 0.266 0.11
Bili T0 [mg/dl] 0.4 (0.3–0.8) 0.1–11.5 0.4 (0.3–0.8) 0.1–2.9 0.699 0.04
Bili T1 [mg/dl] 0.4 (0.3–1) 0.1–16.9 0.4 (0.3–0.5) 0.2–5.1 0.522 0.07
Albumin T0 [g/L] 29.1 (25–34.2) 17.8–44 29.7 (25–34.6) 0.4–40 0.728 0.03
Albumin T1 [g/L] 25.6 (21.7–30.4) 16–38.7 30.5 (26.9–32.5) 23–37 0.014 0.27
LDH T0 [U/L] 194.5 (154–290.8) 114–1878 205 (141–266) 70–761 0.91 0.01
LDH T1 [U/L] 205 (159–311) 41–630 206 (157–286.3) 106–578 0.867 0.02
GOT T0 [U/L] 24.5 (18–42.5) 6–332 25 (16–40) 12–332 0.746 0.03
GOT T1 [U/L] 28 (19–44.8) 11–324 26 (18.8–48.3) 13–151 0.86 0.02
GPT T0 [U/L] 18 (11–33) 5–289 14 (9.8–31.5) 5–374 0.589 0.05
GPT T1 [U/L] 21.5 (14.3–41) 8–251 33 (16.3–49.8) 8–139 0.371 0.10
gGT T0 [U/L] 88.5 (41.5–236) 10–2,884 66 (37–300) 15–706 0.879 0.01
gGT T1 [U/L] 158.5 (75–385) 13–2,190 155.5 (53.5–395) 21–925 0.95 0.01
AlkP T0 [U/L] 111.5 (78.3–211.8) 38–1,690 89 (71–309) 58–826 0.734 0.03
AlkP T1 [U/L] 164 (103–338) 41–2,496 164 (107.3–339) 47–920 0.8 0.03
CRP T0 [mg/dl] 6.3 (2.9–13.2) 0–46.4 5.1 (2.3–13.5) 1–23 0.541 0.06
CRP T1 [mg/dl] 8.9 (4–18.9) 0.4–41.3 7.2 (5.1–10.3) 0.5–18.5 0.218 0.13
Leukocytes T0 [G/L] 8.1 (6.2–13.6) 1.9–65.4 7.5 (4.6–10.2) 1.4–18.8 0.192 0.12
Leukocytes T1 [G/L] 10.6 (7.2–13.8) 2–99.6 7.3 (5.3–11.4) 1.2–12.5 0.053 0.22
Sodium T0 [mmol/L] 136.5 (133–140) 122–149 137 (134–138) 131–145 0.903 0.01
Sodium T1 [mmol/L] 138 (132.5–141.5) 126–154 137 (134–139.8) 124–143 0.648 0.05
Creatinine T0 [mg/dl] 0.7 (0.6–1.1) 0.3–4 0.6 (0.5–0.8) 0.3–1.5 0.141 0.14
Creatinine T1 [mg/dl] 0.7 (0.5–1.4) 0.2–6 0.7 (0.5–0.8) 0.3–1.7 0.247 0.13
Magnesium T0 [mmol/L] 0.7 (0.7–0.9) 0.4–1.3 0.7 (0.7–0.8) 0.4–0.9 0.771 0.03
Calcium T0 [mmol/L] 2.1 (2–2.2) 1.1–3.4 2.2 (2–2.3) 1.9–2.8 0.282 0.10
Potassium T0 [mmol/L] 3.8 (3.4–4.1) 2.6–6 3.9 (3.2–4.1) 2.8–4.9 0.823 0.02
Potassium T1 [mmol/L] 4 (3.5–4.3) 0.5–5.8 4.1 (3.8–4.4) 3.2–6.4 0.301 0.11
Urea T0 [mg/dl] 19 (11.7–29.3) 2–76 11 (9.3–20.5) 3.9–34.3 0.016 0.23
Uric Acid T0 [mg/dl] 4.9 (3.4–8.3) 1.2–26.4 4.1 (3.1–6.4) 2–9 0.193 0.13
CRP/albumin ratio T0 0.2 (0.1–0.5) 0–1.9 0.2 (0.1–0.5) 0–5.3 0.969 0.00
CRP/albumin ratio T1 0.3 (0.1–0.8) 0–1.9 0.3 (0.1–0.4) 0–0.8 0.092 0.18
Bili diff 0 (− 0.2 - 0.3) −10.6 - 14.4 0 (− 0.2–0.1) −1.1 - 3.3 0.499 0.08
Albumin diff −4.4 (− 8.2 - 1.2) −18.7 - 11 −0.1 (− 4.1–4.1) −8.1 - 28.6 0.037 0.24
LDH diff 6.5 (− 28–52.8) −285 - 245 −9.5 (− 41.5–29.8) −85 - 176 0.383 0.10
GOT diff 3 (− 4–13.3) −238 - 247 2.5 (− 5.8–12.3) −181 - 28 0.57 0.06
GPT diff 3 (− 6–18) −175 - 193 3 (− 6–23) −235 - 37 0.882 0.02
gGT diff 54.5 (− 14.3–174.3) −1,386 - 1341 77 (− 4–215) −188 - 307 0.797 0.03
AlkP diff 37 (1–92) −233 - 1085 29 (− 14–113.3) −65 - 354 0.639 0.05
CRP diff 2.6 (− 2.4–7.4) −30.8 - 35.2 2 (− 2.8–4.2) −12.6 - 6.9 0.165 0.15
Leukocytes diff 1.5 (− 3.5–5.9) −41.5 - 34.3 1.3 (− 2.2–2.9) −10.1 - 3.7 0.434 0.09
Sodium diff 0.5 (− 3–4.8) −11 - 15 0 (− 2–3) −12 - 8 0.656 0.05
Creatinine diff −0.1 (− 0.2–0.1) −1.7 - 4.3 0 (− 0.2–0.2) −0.4 - 0.7 0.745 0.04
Potassium diff 0.1 (− 0.3–0.6) −2.9 - 2 0.2 (− 0.2–0.6) −0.7 - 3.4 0.439 0.09
CRP/albumin ratio diff 0.1 (0–0.4) −1.25 - 1.86 0.1 (− 0.2–0.1) −5.1 - 0.3 0.059 0.21

Parameters with an effect size r > 0.2 are highlighted in bold. Diff = difference in the respective parameter from T0 to T1. BMI, body mass index. Bili, bilirubin. LDH, lactate dehydrogenase. GOT, serum glutamic oxaloacetic transaminase. GPT, serum glutamic pyruvic transaminase. gGT, gamma-glutamyl transferase. AlkP, alkaline phosphatase. CRP, C-reactive protein.